ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag european medicines agency ecology immunology microbiology culture

Updated Sept 1
coronavirus pandemic news articles covid-19 sars-cov-2 virology research science
Follow the Coronavirus Outbreak
The Scientist | Feb 20, 2020 | 10+ min read
Saliva tests screen staff and students at University of Illinois; Study ranks species most susceptible to SARS-CoV-2 infection; COVID-19 clinical trials test drugs that inhibit kinin system
Wrestling with Recurrent Infections
Gayatri Vedantam and Glenn S. Tillotson | May 1, 2011 | 10+ min read
Clostridium difficile is evolving more robust toxicity, repeatedly attacking its victims, and driving the search for alternative therapies to fight the infection.
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.
Viral Soldiers
Jyoti Madhusoodanan | Jan 1, 2016 | 10+ min read
Phage therapy to combat bacterial infections is garnering attention for the second time in 100 years, but solid clinical support for its widespread use is still lacking.
Going Viral
Breeann Kirby and Jeremy J. Barr | Sep 1, 2013 | 10+ min read
From therapeutics to gene transfer, bacteriophages offer a sustainable and powerful method of controlling microbes.
Wrestling with Recurrent Infections
Gayatri Vedantam and Glenn S. Tillotson | May 1, 2011 | 9 min read
By Gayatri Vedantam and Glenn S. Tillotson Wrestling with Recurrent Infections Clostridium difficile is evolving more robust toxicity, repeatedly attacking its victims, and driving the search for alternative therapies to fight the infection. photoillustration by Sean Mccabe; Science Photo Library (boy); Sebastian Kaulitzki/ Istockphoto.com (Intestines); Olena Timashova/Istockphoto.com (Green bacteria); Jiri Flogel/Istockphoto.com (Blue bacteria) As infectiou
World Bank And Its New Adviser On Human Development Strive To Improve The Health Of Impoverished Populations
Steve Sternberg | Feb 4, 1996 | 8 min read
Strive To Improve The Health Of Impoverished Populations Author: Steve Sternberg The World Bank, once a stronghold of public-spirited but nonscientific economists, has over the past decade emerged as the major financier of research to improve the health of people in Third World countries. Banking on Health: Richard G.A. Feachem, World Bank senior adviser on human development, has put health at the top of the bank's agenda. Each year, the World Bank invests $2 billion for health programs in i
Legions Of Life Scientists Will Be Called To The Front, As War On AIDS Intensifies
Ricki Lewis | Jun 27, 1993 | 9 min read
With the pandemic mounting and no sure remedies in sight, experts foresee the growing recruitment of skilled researchers On May 21, the World Health Organization announced that 14 million people have been infected with HIV so far, and the global figure could hit 40 million by the year 2000. And the ninth international AIDS meeting in Berlin earlier this month yielded little startling information beyond the general agreement among scientists that they have been, in effect, stymied thus f
Deliberating Over Danger
The Scientist | Apr 1, 2012 | 10+ min read
The creation of H5N1 bird flu strains that are transmissible between mammals has thrown the scientific community into a heated debate about whether such research should be allowed and how it should be regulated.

Run a Search

ADVERTISEMENT